The Role of Phosphatidylinositol 3-Kinase Signaling Pathways in Pancreatic Cancer
References (96)
- et al.
Treatment for pancreatic cancer: current therapy and continued progress
Gastroenterology
(2005) - et al.
Pancreatic cancer: basic and clinical aspects
Gastroenterology
(2005) - et al.
Cytotoxic therapy for advanced pancreatic adenocarcinoma
Semin Oncol
(2007) - et al.
Class IA phosphatidylinositol 3-kinase signaling in non-small cell lung cancer
J Thorac Oncol
(2009) - et al.
Transcriptional regulation of Akt activation by E2F
Mol Cell
(2004) - et al.
E2F1 inhibits c-Myc-driven apoptosis via PIK3CA/Akt/ mTOR and COX-2 in a mouse model of human liver cancer
Gastroenterology
(2008) - et al.
Inappropriate activation of the TSC/Rheb/mTOR/S6K cassette induces IRS1/2 depletion, insulin resistance, and cell survival deficiencies
Curr Biol
(2004) - et al.
Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCα, but not S6K1
Dev Cell
(2006) - et al.
Irs-1: auditing the effectiveness of mTOR inhibitors
Cancer Cell
(2006) - et al.
Cancer cell metabolism: Warburg and beyond
Cell
(2008)
Stem cell factor/c-kit signaling enhances invasion of pancreatic cancer cells via HIF-lα under normoxic condition
Cancer Lett
(2011)
NADPH oxidase activation in pancreatic cancer cells is mediated through Akt-dependent up-regulation of p22phox
J Biol Chem
(2011)
Function of fibroblast growth factors and vascular endothelial growth factors and their receptors in angiogenesis
Crit Rev Oncol Hematol
(2000)
Pancreatic cancer cell proliferation is phosphatidylinositol 3-kinase dependent
J Surg Res
(2000)
Akt phosphorylation of bad couples survival signals to the cell-intrinsic death machinery
Cell
(1997)
Inhibition of Akt abrogates chemotherapy-induced NFκB survival mechanisms: implications for therapy in pancreatic cancer
J Am Coll Surg
(2004)
EGF promotes invasion by PANC-1 cells through Rac1/ROS-dependent secretion and activation of MMP-2
Biochem Biophys Res Commun
(2009)
Hypoxia-reoxygenation increase invasiveness of PANC-1 cells through Rac1/MMP-2
Biochem Biophys Res Commun
(2010)
IGF-1 mediates PTEN suppression and enhances cell invasion and proliferation via activation of the IGF-1/ PI3K/Akt signaling pathway in pancreatic cancer cells
J Surg Res
(2010)
A pharmacological map of the PI3-K family defines a role for p110α in insulin signaling
Cell
(2006)
Gastrointestinal growth factors and hormones have divergent effects on Akt activation
Cell Signal
(2009)
Inhibition of Notch3 enhances sensitivity to gemcitabine in pancreatic cancer through an inactivation of PI3K/Akt-dependent pathway
Med Oncol
(2010)
Apoptosis: targets in pancreatic cancer
Mol Cancer
(2003)
Cancer burden in the year 2000. The global picture
Eur J Cancer
(2001)
Cancer statistics, 2010
CA Cancer J Clin
(2010)
Recent advances and developments in treatment strategies against pancreatic cancer
Curr Clin Pharmacol
(2009)
Tumour growth and resistance to gemcitabine of pancreatic cancer cells are decreased by ap-2α overex-pression
Br J Cancer
(2009)
Core signaling pathways in human pancreatic cancers revealed by global genomic analyses
Science
(2008)
Pik3ca mutations in intraductal papillary mucinous neoplasm/carcinoma of the pancreas
Clin Cancer Res
(2006)
DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors
Science
(2011)
Class I PI3K in oncogenic cellular transformation
Oncogene
(2008)
The phosphoinositol-3-kinase-protein kinase B/Akt pathway is critical for pseudomonas aeruginosa strain PAK internalization
Mol Biol Cell
(2005)
The PI3K-PDK1 connection: more than just a road to PKB
Biochem J
(2000)
The phosphoinositide 3-kinase pathway
Science
(2002)
Crosstalk between phosphatidylinositol 3-kinase/ Akt and c-Jun NH2-terminal kinase mediates survival of isolated human islets
Endocrinology
(2004)
Phosphoinositide-3-kinase signaling controls S-phase kinase-associated protein 2 transcription via E2F1 in pancreatic ductal adenocarcinoma cells
Cancer Res
(2007)
PI3K signaling maintains c-Myc expression to regulate transcription of E2F1 in pancreatic cancer cells
Mol Carcinog
(2009)
Antagonism of E2F-1 regulated BNIP3 transcription by NF-κB is essential for basal cell survival
Proc Natl Acad Sci USA
(2008)
Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization
Genes Dev
(1998)
The renaissance of GSK3
Nat Rev Mol Cell Biol
(2001)
Oncogenic PI3K deregulates transcription and translation
Nat Rev Cancer
(2005)
Akt as a therapeutic target in cancer
Expert Opin Ther Targets
(2008)
Negative regulation of TSC1-TSC2 by mammalian D-type cyclins
Cancer Res
(2005)
Loss of TSC1/ TSC2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR
J Clin Invest
(2003)
PDGFRs are critical for PI3K/ Akt activation and negatively regulated by mTOR
J Clin Invest
(2007)
The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins
J Cell Biol
(2004)
Genetic analysis of PTEN and Tsc2 functional interactions in the mouse reveals asymmetrical haploinsufficiency in tumor suppression
Genes Dev
(2005)
Pancreatic endocrine tumors: expression profiling evidences a role for Akt-mTOR pathway
J Clin Oncol
(2010)
Cited by (0)
- 1
Prof. Roland Andersson Department of Surgery, Clinical Sciences Lund Skåne University Hospital Lund SE-221 85 Lund (Sweden) Tel. +46 46 17 23 59
Copyright © 2011 IAP and EPC. Published by Elsevier India, a division of Reed Elsevier India Pvt. Ltd. Published by Elsevier India, a division of Reed Elsevier India Pvt. Ltd. All rights reserved.